New drugs, old drugs. Beta-adrenoceptor blocking agents
Krum, H.; Pillay, P.
Medical Journal of Australia 168(5): 232-235
1998
ISSN/ISBN: 0025-729X PMID: 9539903 Document Number: 488727
Document emailed within 1 workday
Related Documents
Lorimer, A.R.; Jones, J.V.; Clark, B.; Dunn, F.G.; Melville, D.; Lawrie, T.D. 1976: Indications for beta-adrenoceptor blocking drugs in hypertension Postgraduate Medical Journal 52(Suppl 4): 81-85Hellenbrecht, D.; Enenkel, J. 1984: Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat Arzneimittel-Forschung 34(9): 980-983
Elonen, E. 1975: Effect of beta-adrenoceptor blocking drugs, physostigmine, and atropine on the toxicity of doxepin in mice Medical Biology 53(4): 231-237
Shanks, R.G. 1981: Review of a review. Partial agonist activity of beta-adrenoceptor blocking drugs European Heart Journal 2(3): 253-255
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Mazurowa, A.; Szadowska, A.; Szmigielski, A. 1972: Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs Kardiologia Polska 15(2): 167-175
Imai, S. 1975: Action mechanism of anti-hypertensive drugs, with special reference to beta blocking drugs Nihon Jinzo Gakkai Shi 17(7): 674-677
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Conway, J. 1980: The antihypertensive action of beta-adrenoceptor blocking agents Archives Internationales de Pharmacodynamie et de Therapie Suppl: 83-91
Mostaghim, R.; Maddox, Y.T.; Ramwell, P.W. 1986: Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents Journal of Pharmacology and Experimental Therapeutics 239(3): 797-801
Schneider, R.E.; Bishop, H.; Kendall, M.J.; Quarterman, C.P. 1981: Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents International Journal of Clinical Pharmacology Therapy and Toxicology 19(4): 158-162
Hellenbrecht, D.; Gortner, L. 1976: Correlations between hydrophobicity and non-specific pharmacological effects of beta-adrenoceptor blocking agents Polish Journal of Pharmacology and Pharmacy 28(6): 625-630
Schulte, K.L.; Meyer-Sabellek, W.; Thiede, H.M.; Röcker, L.; Gotzen, R. 1987: Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol International Journal of Clinical Pharmacology Therapy and Toxicology 25(10): 539-544
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Slawin, S. 1973: Beta adrenergic blocking drugs Harefuah 85(4): 178-183
Fredholm, B.B.; Lunell, N.O.; Persson, B.; Wager, J. 1982: Development of tolerance to the metabolic actions of beta 2-adrenoceptor stimulating drugs Acta Obstetricia et Gynecologica Scandinavica. Supplement 108: 53-59
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Walters, L.; Dormehl, I.; Goosen, D.J.; Avenant, J.C.; Du Plessis, M.; Jacobs, N.; Schoeman, H.S. 1983: Beta-adrenergic blocking drugs and renal function South African Medical Journal 64(15): 572-573
Khanna, N.; Ray, A.; Alkondon, M.; Sen, P. 1989: Effect of beta-adrenoceptor antagonists and some related drugs on maximal electroshock seizures in mice Indian Journal of Experimental Biology 27(2): 128-130